Deverra
Universal donor cell therapies to defeat cancer
Seattle, United States · Founded 2019 · $2.4M raised
- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- deverratx.com
- Total Funding
- $2.4M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Deverra Therapeutics is a clinical-stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for cancer and infectious diseases. The company holds an exclusive license to a proprietary Notch-mediated stem cell expansion and directed differentiation platform from the Fred Hutchinson Cancer Research Center, built on more than 20 years of federally funded research and multiple clinical trials. Deverra's innovative platform generates a range of unmodified and engineered progenitor and immune cells designed to boost the patient's blood and immune system to eliminate cancer and virally infected cells. The company's team includes pioneers who were the first to demonstrate clinical effectiveness using expanded stem cell therapies and non-HLA matched, universal donor cell therapies.
Summary
Deverra is a Biotech company based in Seattle, United States, founded in 2019. It has raised $2.4M in total across 1 round.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/deverra"><img src="https://indexed.vc/api/badge/company/deverra" alt="Deverra on Indexed.vc" width="260" height="76" /></a>